Want to know what's happening next in healthcare?

MedCityNews is the leading online news source for the business of innovation in healthcare.


“I read MedCity because it captures the pulse of what's going on in healthcare innovation, a go to source. I also like how MedCity supports women in digital health.”

Dr. Charlene Ngamwajasat, @doctorcharlene, Physician and techie


Sign up for our daily newsletter


Depression mood-tracking app simplifies communication between therapists, patients

5:30 am by | 0 Comments

depression

Aiden, an app hoping to simplify communication between patients who suffer from depression and their therapists, has won the grand final of this year’s StartupBus Europe Tour.

Currently, Kristina Wilms, from Germany, is at the Pioneers Festival in Vienna building up her app’s first prototype in preparation to pitch at the hackathon ending the two-day conference.

The idea, which won the AppHappening Innovation Contest and helped Wilms secure a spot on StartupBus Europe, was inspired by her own struggles with depression.

“One of the most important elements in the treatment of depression and burn-out is the recording of the persons’ behavior patterns,” she said.

“At the moment, patients are asked to fill out special forms which they have to carry around all day and are both indiscreet and impractical.”

Here’s a video demo:

One of Aiden’s core features will be to help patients report detailed accounts of mood and feelings into the mobile app in real-time so healthcare professionals can receive accurate data. As for the business model, Wilms hopes to license the app to therapists, who would then supply it to patients suffering from depression.

This story originally appeared on VentureVillage.

This article originally appeared on VentureBeat

Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

By Charmaine Li, VentureVillage

Visit website | More posts by Author

0 comments

Hear the latest news first

Get our daily newsletter or follow us.

 

Advertisement